← Leaderboards
John K Amory
University Of Washington
$37,632,597
Attributed
$39,092,482
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.5M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$39,092,482 · 13
By mechanism
UL1$20,707,387 · 1
KL2$9,778,821 · 1
U54$3,757,833 · 2
R01$1,903,737 · 1
U01$1,447,304 · 1
K24$637,540 · 1
Top collaborators
- Christy Michelle Mckinney4 shared
Most similar at University Of Washington
Same institution · by research overlap
- Mary L. Disis$210,448,010
Others in their field
Top investigators on “Male”
- Myron E Essex · Harvard University (Sch Of Public Hlth)$47,217,905
- Kc Kent Lloyd · University Of California At Davis$33,183,422
- Linda A Teplin · Northwestern University$32,082,912
- Beth Baseler · Leidos Biomedical Research, Inc.$30,337,006
- Edie C Goldsmith · University Of South Carolina At Columbia$30,062,912
- Kevin A. Pelphrey · University Of California Los Angeles$29,809,496
Research focus
MaleOralSpermatogenesisContraceptive AgentsAnabolismInhibitor/AntagonistSerumTretinoinMale Contraceptive AgentsPlacebosLiverResearch StudyTrainingMale ContraceptionsEnzymesProgramsStructureAldehyde DehydrogenasesIn VivoIsoenzymesOral AdministrationResearch PersonnelAreaEthanol Metabolism
Grant awards (50)
Institute of Translational Health Sciences$10,189,073
UL1 · FY2025 · TR · contact PI
Institute of Translational Health Sciences$10,364,077
UL1 · FY2024 · TR · contact PI
Institute of Translational Health Sciences$154,237
UL1 · FY2024 · TR · contact PI
Institutional Career Development Core$1,226,524
KL2 · FY2023 · TR · contact PI
ALDH1A1/A2 Inhibitors for Male Contraception$374,912
R01 · FY2023 · HD · contact PI
Institutional Career Development Core$182,162
KL2 · FY2023 · TR · contact PI
Institutional Career Development Core$135,563
KL2 · FY2023 · TR · contact PI
Institutional Career Development Core$1,375,521
KL2 · FY2022 · TR · contact PI
ALDH1A1/A2 Inhibitors for Male Contraception$374,912
R01 · FY2022 · HD · contact PI
Institute of Translational Health Sciences$1,446,460
KL2 · FY2021 · TR · contact PI
ALDH1A1/A2 Inhibitors for Male Contraception$374,912
R01 · FY2021 · HD · contact PI
Institute of Translational Health Sciences$1,445,432
KL2 · FY2020 · TR · contact PI
ALDH1A1/A2 Inhibitors for Male Contraception$382,563
R01 · FY2020 · HD · contact PI
Institute of Translational Health Sciences$1,327,758
KL2 · FY2019 · TR · contact PI
ALDH1A1/A2 Inhibitors for Male Contraception$396,438
R01 · FY2019 · HD · contact PI
Retinoic Acid in Male Infertility$127,508
K24 · FY2019 · HD · contact PI
NCCIH Supplement to NCATS/CTSA Program for KL2 Scholars - M. Sodders$118,299
KL2 · FY2019 · TR · contact PI
Institute of Translational Health Sciences$1,190,475
KL2 · FY2018 · TR · contact PI
Retinoic Acid in Male Infertility$127,508
K24 · FY2018 · HD · contact PI
Institute of Translational Health Sciences$1,330,627
KL2 · FY2017 · TR · contact PI
Retinoic Acid in Male Infertility$127,508
K24 · FY2017 · HD · contact PI
Novel Specific Inhibitors of ALDH1A2 for Male Contraception$264,239
U54 · FY2016 · HD · contact PI
Retinoic Acid in Male Infertility$127,508
K24 · FY2016 · HD · contact PI
Novel Specific Inhibitors of ALDH1A2 for Male Contraception$266,630
U54 · FY2015 · HD · contact PI
Retinoic Acid in Male Infertility$127,508
K24 · FY2015 · HD · contact PI
Novel Specific Inhibitors of ALDH1A2 for Male Contraception$260,212
U54 · FY2014 · HD · contact PI
BDADs for Male Contraception$256,121
U01 · FY2013 · HD · contact PI
Novel Specific Inhibitors of ALDH1A2 for Male Contraception$239,845
U54 · FY2013 · HD · contact PI
Novel Specific Inhibitors of ALDH1A2 for Male Contraception$322,917
U54 · FY2012 · HD · contact PI
BDADs for Male Contraception$265,248
U01 · FY2012 · HD · contact PI
Oral Testosterone for Male Hormonal Contraception$512,502
U54 · FY2011 · HD · contact PI
BDADs for Male Contraception$267,948
U01 · FY2011 · HD · contact PI
Oral Testosterone for Male Hormonal Contraception$547,976
U54 · FY2010 · HD · contact PI
BDADs for Male Contraception$268,416
U01 · FY2010 · HD · contact PI
BDADs for Male Contraception$99,275
U01 · FY2010 · HD · contact PI
Oral Testosterone for Male Hormonal Contraception$482,566
U54 · FY2009 · HD · contact PI
BDADs for Male Contraception$285,008
U01 · FY2009 · HD · contact PI
BDADs for Male Contraception$5,288
U01 · FY2009 · HD · contact PI
Oral Testosterone for Male Hormonal Contraception$430,961
U54 · FY2008 · HD · contact PI
Oral Androgen Administration and Function in Man$126,023
K23 · FY2008 · HD · contact PI
Oral Testosterone for Male Hormonal Contraception$429,985
U54 · FY2007 · HD · contact PI
Oral Androgen Administration and Function in Man$126,044
K23 · FY2007 · HD · contact PI
ORAL ANDROGENS IN MAN-4: GONADOTROPIN SUPPRESSION$4,873
M01 · FY2007 · RR · contact PI
ORAL ANDROGENS IN MAN-3: PK OF ORAL TESTOSTERONE BY ALPHA5-DUTASTERIDE$4,109
M01 · FY2007 · RR · contact PI
Oral Androgen Administration and Function in Man$126,021
K23 · FY2006 · HD · contact PI
ORAL ANDROGENS IN MAN-3: PK OF ORAL TESTOSTERONE BY ALPHA5-DUTASTERIDE$88,488
M01 · FY2006 · RR · contact PI
Oral Androgen Administration and Function in Man$125,954
K23 · FY2005 · HD
ORAL ANDROGENS IN MAN-2: PK OF ORAL TESTOSTERONE WITH 5 -REDUCTASE$74,168
M01 · FY2005 · RR
Oral Androgen Administration and Function in Man$125,627
K23 · FY2004 · HD
Oral androgens in Man-1: Single-dose PK of oral testosterone and esters$58,553
M01 · FY2004 · RR